Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial.
Journal: Nature medicine
Published: October 03, 2025
Anti-CD79B Antibody-Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 10, 2021
A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia.
Journal: American journal of hematology
Published: February 03, 2021
Bimodal expression of potential drug target CLL-1 (CLEC12A) on CD34+ blasts of AML patients.
Journal: European journal of haematology
Published: October 28, 2020
PRPs localized to the middle lamellae are required for cortical tissue integrity in Medicago truncatula roots.
Journal: Plant molecular biology
Published: August 31, 2019
Identifying stem cell gene expression patterns and phenotypic networks with AutoSOME.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 19, 2014
Showing 1-7 of 7
Last Updated: 09/26/2026